Copy

Tuesday, 23 July 2019

World Health Organisation Certifies New HIV Treatment Drug


The World Health Organisation (WHO) has certified Dolutegravir (DTG) as a safe and preferred first-line and second-line treatment drug for HIV/AIDS, adding that pregnant women can also use it.

In a statement posted on its official website on Monday, it said initial studies had flagged DTG as having a possible link with neural tube defects (birth defects of the brain and spinal cord that cause conditions such as spina bifida) in infants born to women using the drug at the time of conception.

Consequently, based on these preliminary findings, many countries had advised pregnant women and women of childbearing potential to take efavirenz (EFV) instead, the release said.

“However, new data from two large clinical trials comparing the efficacy and safety of DTG and EFV in Africa have now expanded the evidence base.”

WHO said according to new data, risks of neural tube defects are significantly lower when using DTG than what the initial studies may have suggested.

The agency described DTG as an HIV drug that is more effective, easier to take and has fewer side effects than alternative drugs that are currently used.

No comments:

Post a Comment

I’m glad you visited Alabekee’s blog. I love to read your opinion. Please spare me few minutes of your valuable time and drop a comment because it will motivate me to blog better.

DISCLAIMER: Please note that apart from www.alabekee.com, Alabekee does not own any other blog/website. Also bear in mind that comments on this blog are not posted by Alabekee. Alabekee’s blog readers are totally responsible for the comments they post on www.alabekee.com.

Contact me for Inquiries/Tip-offs – alabekee44@gmail.com or Call 08060623254/09051251337

Follow me on Twitter-@AlabekeeOla
Instagram - alabekeesblog
Facebook - Alabekee Ola

Thanks so much for being part of Alabekee’s blog!